Journey Medical (DERM) Equity Ratio (2020 - 2026)

Journey Medical has reported Equity Ratio for 7 years, with the latest figure at 0.34 in Q1 2026.

• For the quarter ending Q1 2026, Equity Ratio rose 32.85% year-over-year to 0.34; the trailing twelve-month figure through Mar 2026 stood at 0.34 (up 32.85% YoY), and the FY2025 full-year result was 0.34, up 34.64% from the prior year.
• Equity Ratio for Q1 2026 stood at 0.34, roughly flat from 0.34 in the prior quarter.
• The five-year high for Equity Ratio was 0.34 in Q1 2022, with the low at 0.0 in Q2 2023.
• Historically, Equity Ratio has averaged 0.23 across 5 years, with a median of 0.25 in 2024.
• Annual changes were most pronounced in 2023 — Equity Ratio sank 99.98% — and 2024, when it surged 241594.88%.
• Journey Medical's Equity Ratio stood at 0.16 in 2022, then surged by 63.98% to 0.26 in 2023, then fell by 5.55% to 0.25 in 2024, then surged by 34.64% to 0.34 in 2025, then climbed by 0.03% to 0.34 in 2026.
• The last three Equity Ratio figures came in at 0.34 (Q1 2026), 0.34 (Q4 2025), and 0.3 (Q3 2025), per Business Quant data.